Healthcare provider profile · identity verified

Lawrence Edward Harbrecht, MD

Internal Medicine · GRAND JUNCTION, CO · NPI 1073001335

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	670	211
Amlodipine Besylate	Amlodipine Besylate	523	163
Losartan Potassium	Losartan Potassium	444	137
Hydrochlorothiazide	Hydrochlorothiazide	401	114
Rosuvastatin Calcium	Rosuvastatin Calcium	365	110
Lisinopril	Lisinopril	329	95
Simvastatin	Simvastatin	326	94
Levothyroxine Sodium	Levothyroxine Sodium	320	92
Omeprazole	Omeprazole	231	75
Metoprolol Succinate	Metoprolol Succinate	212	67
Tamsulosin Hcl	Tamsulosin Hcl	199	59
Metformin Hcl	Metformin Hcl	194	61
Furosemide	Furosemide	186	61
Eliquis	Apixaban	181	44
Gabapentin	Gabapentin	176	46
Metformin Hcl Er	Metformin Hcl	149	50
Pravastatin Sodium	Pravastatin Sodium	143	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	23
Allopurinol	Allopurinol	109	29
Metoprolol Tartrate	Metoprolol Tartrate	106	35
Pantoprazole Sodium	Pantoprazole Sodium	106	33
Carvedilol	Carvedilol	105	34
Tramadol Hcl	Tramadol Hcl	103	32
Albuterol Sulfate Hfa	Albuterol Sulfate	102	39
Jardiance	Empagliflozin	101	25
Montelukast Sodium	Montelukast Sodium	99	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	94	25
Zolpidem Tartrate	Zolpidem Tartrate	90	32
Clopidogrel	Clopidogrel Bisulfate	87	29
Escitalopram Oxalate	Escitalopram Oxalate	87	30
Alendronate Sodium	Alendronate Sodium	83	26
Trazodone Hcl	Trazodone Hcl	82	27
Atenolol	Atenolol	78	21
Potassium Chloride	Potassium Chloride	77	26
Ezetimibe	Ezetimibe	76	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	22
Glimepiride	Glimepiride	69	21
Synthroid	Levothyroxine Sodium	65	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	13
Chlorthalidone	Chlorthalidone	62	17
Diazepam	Diazepam	58	16
Spironolactone	Spironolactone	58	20
Alprazolam	Alprazolam	57	15
Sertraline Hcl	Sertraline Hcl	57	20
Hydralazine Hcl	Hydralazine Hcl	56	19
Glipizide Er	Glipizide	54	16
Methylprednisolone	Methylprednisolone	54	49
Trulicity	Dulaglutide	54	13
Fluticasone Propionate	Fluticasone Propionate	53	24
Citalopram Hbr	Citalopram Hydrobromide	52	17
Nifedipine Er	Nifedipine	51	12
Bupropion Xl	Bupropion Hcl	50	18
Clonazepam	Clonazepam	50	suppressed
Januvia	Sitagliptin Phosphate	50	14
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Xarelto	Rivaroxaban	47	11
Tizanidine Hcl	Tizanidine Hcl	45	23
Duloxetine Hcl	Duloxetine Hcl	43	12
Ozempic	Semaglutide	43	12
Finasteride	Finasteride	42	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	41	suppressed
Farxiga	Dapagliflozin Propanediol	40	11
Esomeprazole Magnesium	Esomeprazole Magnesium	38	11
Doxycycline Hyclate	Doxycycline Hyclate	37	22
Lorazepam	Lorazepam	36	suppressed
Prednisone	Prednisone	36	19
Warfarin Sodium	Warfarin Sodium	35	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Hydrocortisone	Hydrocortisone	33	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Pregabalin	Pregabalin	31	13
Mounjaro	Tirzepatide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Famotidine	Famotidine	29	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Ibuprofen	Ibuprofen	23	suppressed
Ramipril	Ramipril	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Baclofen	Baclofen	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Minoxidil	Minoxidil	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	16
Nitroglycerin	Nitroglycerin	21	11
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Cephalexin	Cephalexin	19	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Cefdinir	Cefdinir	16	15
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Azithromycin	Azithromycin	15	14
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Belsomra	Suvorexant	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Invokana	Canagliflozin	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Naproxen	Naproxen	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lyrica	Pregabalin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nucynta	Tapentadol Hcl	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error